Cited by 237MRI in cancer diagnosisBreast Lesions and CarcinomasBreast Cancer Treatment Studies

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

Open access

Lobbes, M. B. I., Prevos, R., Smidt, M., Tjan-Heijnen, V. C. G., van Goethem, M., Schipper, R., Beets-Tan, R. G., Wildberger, J. E.·2013·Insights into Imaging

DOI 10.1007/s13244-013-0219-yPMC PMC3609956

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVES: This systematic review aimed to assess the role of magnetic resonance imaging (MRI) in evaluating residual disease extent and the ability to detect pathologic complete response (pCR) after neoadjuvant chemotherapy for invasive breast cancer. METHODS: PubMed, the Cochrane Library, MEDLINE, and Embase databases were searched for relevant studies published until 1 July 2012. After primary selection, two reviewers independently assessed the content of each eligible study using a standardised extraction form and pre-defined inclusion and exclusion criteria. RESULTS: A total of 35 eligible studies were selected. Correlation coefficients of residual tumour size assessed by MRI and pathology were good, with a median value of 0.698. Reported sensitivity, specificity, positive predictive value and negative predictive value for predicting pCR with MRI ranged from 25 to 100 %, 50-97 %, 47-73 % and 71-100 %, respectively. Both overestimation and underestimation were observed. MRI proved more accurate in determining residual disease than physical examination, mammography and ultrasound. Diagnostic accuracy of MRI after neoadjuvant chemotherapy could be influenced by treatment regimen and breast cancer subtype. CONCLUSIONS: Breast MRI accuracy for assessing residual disease after neoadjuvant chemotherapy is good and surpasses other diagnostic means. However, both overestimation and underestimation of residual disease extent could be observed. MAIN MESSAGES: • Breast MRI accuracy for assessing residual disease is good and surpasses other diagnostic means. • Correlation coefficients of residual tumour size assessed by MRI and pathology were considered good. • However, both overestimation and underestimation of residual disease were observed. • Diagnostic accuracy of MRI seems to be affected by treatment regimen and breast cancer subtype.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s13244-013-0219-y

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 Detailed overview of study selectionCC BY-NC · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Diagnostic Accuracy of Mammography, Clinical Examination, US, and MR Imaging in Preoperative Assessment of Breast Cancer
Berg, W. A., Gutierrez, L., NessAiver, M. S., Carter, W. B., Bhargavan, M., Lewis, R. S., & Ioffe, O. B. (2004) · Radiology · doi:10.1148/radiol.2333031484 · Cited by 1,441
Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis
Mauri, D., Pavlidis, N., & Ioannidis, J. P. A. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji021 · Cited by 1,214
Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography
Carney, P. A., Miglioretti, D. L., Yankaskas, B. C., Kerlikowske, K. M., Rosenberg, R., Rutter, C. M., Geller, B. M., Abraham, L., Taplin, S. H., Dignan, M., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00008 · Cited by 1,144
Overview of resistance to systemic therapy in patients with breast cancer
Gonzalez-Angulo, A. M., Morales-Vasquez, F., & Hortobagyi, G. N. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74039-3_1 · Cited by 904
Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIAL
Hylton, N. M., Blume, J. D., Bernreuter, W. K., Pisano, E. D., Rosen, M. A., Morris, E. A., Weatherall, P. T., Lehman, C. D., Newstead, G. M., Polin, S. M., et al. (2012) · Radiology · doi:10.1148/radiol.12110748 · Cited by 499
Prospective Comparison of Mammography, Sonography, and MRI in Patients Undergoing Neoadjuvant Chemotherapy for Palpable Breast Cancer
Yeh, E. D., Slanetz, P. J., Kopans, D. B., Rafferty, E. A., Georgian-Smith, D., Moy, L. P., Halpern, E. F., Moore, R. H., Kuter, I., & Taghian, A. G. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.184.3.01840868 · Cited by 400
Accuracy of MR Imaging for Revealing Residual Breast Cancer in Patients Who Have Undergone Neoadjuvant Chemotherapy
Partridge, S. C., Gibbs, J., Lü, Y., Esserman, L. J., Sudilovsky, D., & Hylton, N. M. (2002) · American Journal of Roentgenology · doi:10.2214/ajr.179.5.1791193 · Cited by 337
Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype
Loo, C. E., Straver, M. E., Rodenhuis, S., Muller, S. H., Wesseling, J., Peeters, M.-J. T. F. D. V., & Gilhuijs, K. G. A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.1258 · Cited by 303
Diffusion-weighted MR Imaging: Pretreatment Prediction of Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
Park, S. H., Moon, W. K., Cho, N., Song, I. C., Chang, J. M., Park, I.-A., Han, W., & Noh, D. (2010) · Radiology · doi:10.1148/radiol.10092021 · Cited by 280

Show all 56 references

Sorted by citations

Items 101–200 of 237

Breast Tumor Detection and Classification Using Intravoxel Incoherent Motion Hyperspectral Imaging Techniques
Chan, S., Chang, Y.-C., Huang, P., Ouyang, Y., Chang, Y., Chang, R., Chai, J., Chen, C. C., Chen, H., Chang, C.-I., et al. (2019) · BioMed Research International · doi:10.1155/2019/3843295 · Cited by 13
Role of Magnetic Resonance Imaging in the Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy
Pasquero, G., Surace, A., Ponti, A., Bortolini, M., Tota, D., Mano, M. P., Arisio, R., Benedetto, C., & Baù, M. G. (2020) · In Vivo · doi:10.21873/invivo.11857 · Cited by 13
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution
Antolín, S., Nebril, B. A., Albaina, L., Concha, Á., Santiago, P., García‐Caballero, T., Mosquera, J., Varela, J. R., Soler, R., & Calvo, L. (2018) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s179750 · Cited by 12
Deep-learning based discrimination of pathologic complete response using MRI in HER2-positive and triple-negative breast cancer
Kim, S., Lee, J., Cho, N., & Kim, Y.-G. (2024) · Scientific Reports · doi:10.1038/s41598-024-74276-w · Cited by 11
Accuracy of breast magnetic resonance imaging in evaluating the response to neoadjuvant chemotherapy: a study of 310 cases at a cancer center
Negrão, E. M. S., Bitencourt, A. G. V., de Souza, J. A., & Marques, E. F. (2019) · Radiologia Brasileira · doi:10.1590/0100-3984.2018.0149 · Cited by 11
Evaluating the role of magnetic resonance imaging post‐neoadjuvant therapy for breast cancer in the NEONAB trial
Murphy, C., Mukaro, V. R., Tobler, R., Asher, R., Gibbs, E., West, L., Giuffrè, B., Baron-Hay, S. E., & Khasraw, M. (2017) · Internal Medicine Journal · doi:10.1111/imj.13617 · Cited by 11
Prediction of post transarterial chemoembolization MR images of hepatocellular carcinoma using spatio-temporal graph convolutional networks
Svecic, A., Mansour, R., Tang, A., & Kadoury, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259692 · Cited by 11
Predicting the response to neoadjuvant chemotherapy. Can the addition of tomosynthesis improve the accuracy of contrast-enhanced spectral mammography? A comparison with breast MRI
Savaridas, S., Vinnicombe, S., Warwick, V., & Evans, A. J. (2023) · British Journal of Radiology · doi:10.1259/bjr.20220921 · Cited by 10
Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant Treatment
Onishi, N., Bareng, T. J., Gibbs, J., Li, W., Price, E. R., Joe, B. N., Kornak, J., Esserman, L. J., Newitt, D. C., Hylton, N. M., et al. (2023) · Radiology Imaging Cancer · doi:10.1148/rycan.220126 · Cited by 10
Breast Magnetic Resonance Imaging Performance
Melsaether, A. N., & Gudi, A. (2014) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000035 · Cited by 10
Quantitative mathematical objective evaluation of contrast-enhanced spectral mammogram in the assessment of response to neoadjuvant chemotherapy and prediction of residual disease in breast cancer
Moustafa, A. F. I., Kamal, R. M., Gomaa, M. M. M., Mostafa, S., Mubarak, R. I., & Eladawy, M. (2019) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1186/s43055-019-0041-8 · Cited by 10
Potential Clinical Applications of 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Mammography in Breast Cancer
Cho, I.-H., & Kong, E. (2016) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-016-0446-5 · Cited by 10
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2014
Liedtke, C., Thill, M., Hanf, V., & Schütz, F. (2014) · Breast Care · doi:10.1159/000363591 · Cited by 9
Breast Magnetic Resonance Imaging for Patients With Newly Diagnosed Breast Cancer: A Review
Kim, S., & Cho, N. (2022) · Journal of Breast Cancer · doi:10.4048/jbc.2022.25.e35 · Cited by 9
Multimodal Spatiotemporal Deep Learning Framework to Predict Response of Breast Cancer to Neoadjuvant Systemic Therapy
Verma, M., Abdelrahman, L., Collado‐Mesa, F., & Abdel-Mottaleb, M. S. (2023) · Diagnostics · doi:10.3390/diagnostics13132251 · Cited by 9
Breast cancer abutting the pectoralis major muscle on breast MRI: what are the clinical implications?
Myers, K. S., Stern, E., Ambinder, E. B., & Oluyemi, E. T. (2020) · British Journal of Radiology · doi:10.1259/bjr.20201202 · Cited by 9
Machine learning approaches in the prediction of positive axillary lymph nodes post neoadjuvant chemotherapy using MRI, CT, or ultrasound: A systematic review
Yaghoobpoor, S., Fathi, M., Ghorani, H., Valizadeh, P., Jannatdoust, P., Tavasol, A., Zarei, M., & Arian, A. (2024) · European Journal of Radiology Open · doi:10.1016/j.ejro.2024.100561 · Cited by 8
Magnetic Resonance Imaging of the Breast
Holbrook, A. I., & Newell, M. S. (2016) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000189 · Cited by 8
Diffusion-weighted MR imaging in prediction of response to neoadjuvant chemotherapy in patients with breast cancer
Hu, X., Li, Y., Jin, G., Lai, S., Huang, X., & Su, D. (2017) · Oncotarget · doi:10.18632/oncotarget.18999 · Cited by 8
Cost-effectiveness of ultrasound-guided surgical clips placement for breast cancer localization prior to neoadjuvant chemotherapy
Soliman, A. H., & Osman, A. (2018) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1016/j.ejrnm.2018.06.010 · Cited by 8
Predicting response to neo-adjuvant chemotherapy and assessment of residual disease in breast cancer using contrast-enhanced spectral mammography: a combined qualitative and quantitative approach
Kamal, R. M., Saad, S. M., Moustafa, A. F. I., Gomaa, M. M. M., Mokhtar, O., Gouda, I., Hassan, A., Hilal, A., & ElZayat, A. (2020) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1186/s43055-020-00275-2 · Cited by 8
Omitting Surgery in Complete Responders After Neoadjuvant Chemotherapy: The Quest Continues
Mamounas, E. P. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6678-0 · Cited by 8
Value of mammographic microcalcifications and MRI-enhanced lesions in the evaluation of residual disease after neoadjuvant therapy for breast cancer
Zhu, C., Chen, M., Liu, Y., Li, P., Ye, W., Ye, H., Ye, Y., Liu, Z., Liang, C., & Liu, C. (2023) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-22-1170 · Cited by 7
Performance of Contrast-Enhanced Mammography (CEM) for Monitoring Neoadjuvant Chemotherapy Response among Different Breast Cancer Subtypes
Vidali, S., Irmici, G., Depretto, C., Bellini, C., Pugliese, F., Incardona, L. A., Naro, F. D., Benedetto, D. D., Filippo, G. D., Ferraro, F., et al. (2024) · Cancers · doi:10.3390/cancers16152694 · Cited by 7
Multimodal ultrasound assessment of mass and non-mass enhancements by MRI: Diagnostic accuracy in idiopathic granulomatous mastitis and breast cancer
Yin, L., Wei, X. C., Zhang, Q., Xiang, L., Zhang, Y., Wang, D., Chen, P., Cao, X. D., Shaibu, Z., & Qin, R. (2024) · The Breast · doi:10.1016/j.breast.2024.103797 · Cited by 7
Avoiding breast cancer surgery in a select cohort of complete responders to neoadjuvant chemotherapy: The long-term outcomes
Apte, A., Marsh, S., Chandrasekharan, S., & Chakravorty, A. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102380 · Cited by 7
Contrast-enhanced digital breast tomosythesis and breast MRI to monitor response to neoadjuvant chemotherapy: patient tolerance and preference
Savaridas, S., Whelehan, P., Warwick, V., Vinnicombe, S., & Evans, A. J. (2022) · British Journal of Radiology · doi:10.1259/bjr.20210779 · Cited by 7
Factors associated with radiologic-pathologic discordance in magnetic resonance imaging after neoadjuvant chemotherapy for breast cancer
Kwon, M.-R., Chu, J., Kook, S. H., & Kim, E. Y. (2022) · Clinical Imaging · doi:10.1016/j.clinimag.2022.05.002 · Cited by 7
Breast-Conserving Surgery After Tumor Downstaging by Neoadjuvant Chemotherapy is Oncologically Safe for Stage III Breast Cancer Patients
Bear, H. D. (2014) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2014.01.047 · Cited by 7
An Overview of the Importance of Neoadjuvant Systemic Therapy for Breast Cancer Patients: From the Society of Surgical Oncology and the American Society of Breast Surgeons
Weiss, A., Agnese, D. M., Al‐Hilli, Z., Cabıoğlu, N., Farr, D., Kantor, O., Obeng‐Gyasi, S., & Wilke, L. G. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-17405-7 · Cited by 6
Correlation between MRI morphological response patterns and histopathological tumor regression after neoadjuvant endocrine therapy in locally advanced breast cancer: a randomized phase II trial
Reis, J. S., Thomas, O. M. T., Lahooti, M., Lyngra, M., Schandiz, H., Boavida, J., Gjesdal, K., Sauer, T., Geisler, J., & Geitung, J. T. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06343-z · Cited by 6
Assessment of low-cost surgical metallic clip placement for tumor localization in BIRDAS VI breast cancer patients undergoing neoadjuvant chemotherapy
Shawky-Abdelfatah, N. O., Abdallah, R. H., Ibrahim, S. F., & Ahmed, A. I. (2022) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1186/s43055-022-00740-0 · Cited by 6
Preoperative Breast Magnetic Resonance Imaging as a Predictor of Response to Neoadjuvant Chemotherapy
Browne, R. C., McAnena, P. F., O’Halloran, N., Moloney, B., Crilly, E., Kerin, M. J., & Lowery, A. (2022) · Breast Cancer Basic and Clinical Research · doi:10.1177/11782234221103504 · Cited by 6
Perfusion Imaging by Magnetic Resonance
Sánchez‐Gonzalez, J., Luna, A., & da Cruz, L. C. H. (2013) · Springer eBooks · doi:10.1007/978-3-642-40412-2_16 · Cited by 6
Hypervascularity Predicts Complete Pathologic Response to Chemotherapy and Late Outcomes in Breast Cancer
Bufi, E., Belli, P., Matteo, M. D., Giuliani, M., Tumino, M., Rinaldi, P. M., Nardone, L., Franceschini, G., Mulè, A., & Bonomo, L. (2016) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.06.007 · Cited by 6
The additive role of 1H-magnetic resonance spectroscopic imaging to ensure pathological complete response after neoadjuvant chemotherapy in breast cancer patients
Bayoumi, D., Zaky, M. M., Ibrahim, D. A., Abdallah, A., & Abouelkhair, K. M. (2019) · Polish Journal of Radiology · doi:10.5114/pjr.2019.92282 · Cited by 6
MRI‐based radiomics models for early predicting pathological response to neoadjuvant chemotherapy in triple‐negative breast cancer: A systematic review and meta‐analysis
Zhang, J., Wu, Q., Peng, L., Zhu, X., & Li, B. (2025) · Journal of Applied Clinical Medical Physics · doi:10.1002/acm2.70296 · Cited by 6
Abbreviated breast MRI for evaluating breast cancer before initiation of neoadjuvant chemotherapy: A cross-sectional study
Arian, A., Hashemi, M. G., Talebi, V., Ahmadinejad, N., Eslami, B., Sedighi, N., & Omranipour, R. (2023) · European Journal of Radiology Open · doi:10.1016/j.ejro.2023.100517 · Cited by 5
The Influence of Data-Driven Compressed Sensing Reconstruction on Quantitative Pharmacokinetic Analysis in Breast DCE MRI
Wang, P. N., Velikina, J., Bancroft, L. C. H., Samsonov, A. A., Kelcz, F., Strigel, R. M., & Holmes, J. H. (2022) · Tomography · doi:10.3390/tomography8030128 · Cited by 5
Comparison of diffusion-weighted and contrast-enhanced MRI for monitoring response to neoadjuvant therapy in breast cancer
Eom, H. J., Kim, H. H., Kim, H. J., Choi, W. J., Chae, E. Y., Shin, H. J., & Cha, J. H. (2025) · European Radiology · doi:10.1007/s00330-025-11640-y · Cited by 4
Magnetic resonance imaging-guided single-fraction preoperative radiotherapy for early-stage breast cancer (the RICE trial): feasibility study
Qadir, A., Singh, N., Dean, J., Brown, K., TACEY, M. A., Mann, B. A., Kron, T., Cahoon, G. D., Lau, E. W. F., Scott, A. M., et al. (2024) · Pilot and Feasibility Studies · doi:10.1186/s40814-024-01557-6 · Cited by 4
MRI-based artificial intelligence models for post-neoadjuvant surgery personalization in breast cancer: a narrative review of evidence from Western Pacific
Lin, Y., Cheng, M., Wu, C., Huang, Y., Zhu, T., Li, J., Gao, H., & Wang, K. (2024) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2024.101254 · Cited by 4
The percentage of unnecessary mastectomy due to false size prediction using preoperative ultrasonography and MRI in breast cancer patients who underwent neoadjuvant chemotherapy: a prospective cohort study
Han, Y., Jung, J. G., Kim, J., Lim, C., Kim, H. K., Lee, H., Moon, H., & Han, W. (2023) · International Journal of Surgery · doi:10.1097/js9.0000000000000754 · Cited by 4
Potential of MRI in Assessing Treatment Response After Neoadjuvant Radiation Therapy Treatment in Breast Cancer Patients: A Scoping Review
Qadir, A., Singh, N., Moe, A. A. K., Cahoon, G. D., Lye, J., Chao, M., Foroudi, F., & Uribe, S. A. (2024) · Clinical Breast Cancer · doi:10.1016/j.clbc.2024.05.010 · Cited by 4
MRI Changes in Breast Skin Following Preoperative Therapy for Patients with Inflammatory Breast Cancer
Yeh, E. D., Rives, A. F., Nakhlis, F., Bay, C. P., Harrison, B. T., Bellon, J. R., Remolano, M. C., Jacene, H. A., Giess, C. S., & Overmoyer, B. A. (2021) · Academic Radiology · doi:10.1016/j.acra.2021.08.003 · Cited by 4
Comparison of automated breast volume scanning with conventional ultrasonography, mammography, and MRI to assess residual breast cancer after neoadjuvant therapy by molecular type
Peng, Y., Yuan, F., Xie, F., Yang, H., Wang, S.-H., Wang, C., Yang, Y., Du, W., Liu, M., & Wang, S.-H. (2023) · Clinical Radiology · doi:10.1016/j.crad.2022.12.002 · Cited by 3
Combining Contrast-Enhanced Mammography and Radioactive-Free Magnetic Seed Localization of Non-palpable Breast Tumors: A Feasibility Study
Theunissen, J. E. M., van Haaren, E. R. M., Frotscher, C., Körver‐Steeman, R., Janssen, A., Vissers, Y. L. J., van Bastelaar, J., Valentijn-Morsing, A., Bouwman, L. H., & Lobbes, M. B. I. (2024) · Journal of Cancer · doi:10.7150/jca.98597 · Cited by 3
Self-citation
Tumour volume analysis applied to imaging and histological examinations in breast cancer
Gordon, A. B., Sheeka, A., Cleator, S., Leff, D. R., & Lim, A. K. P. (2025) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2025.109578 · Cited by 3
CEM immediately after contrast-enhanced CT: a one-step staging of breast cancer
Ancona, A., Telegrafo, M., Fella, R. R., Iamele, D., Cantore, S., & Moschetta, M. (2024) · European Radiology Experimental · doi:10.1186/s41747-024-00440-6 · Cited by 3
A Practical Guide to Wireless Breast Localization Devices
Sabato, J. J. D., Kim, J., Sehareen, S., Vincoff, N. S., & Kalantarova, S. (2024) · Applied Radiology · doi:10.37549/ar-d-24-0001 · Cited by 3
Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and tumor expression of metalloproteases and their inhibitors in invasive breast cancer
Cuadriello, E. F., Fernández‐Guinea, O., Eiró, N., González, L. O., Junquera, S., & Vizoso, F. J. (2016) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2016.04.005 · Cited by 3
Breast Imaging and Image-Guided Biopsy Techniques
Ganott, M. A., Griffith, B. M., & Rudzinski, S. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-04606-4_5 · Cited by 3
Contrast-Enhanced Mammogram: A New Game-Changer in Breast Imaging. Indications with Case-Based Experience
Chotai, N. C., Loke, S. C., & Yu, T. E. (2021) · Advances in Breast Cancer Research · doi:10.4236/abcr.2021.104016 · Cited by 2
Prediction model for individualized precision surgery in breast cancer patients with complete response on MRI and residual calcifications on mammography after neoadjuvant chemotherapy
Kwon, M.-R., Ko, E. Y., Lee, J. E., Han, B., Ko, E. S., Choi, J. S., Kim, H., Kim, M. K., Yu, J. H., Lee, H., et al. (2024) · Breast Cancer · doi:10.1007/s12282-024-01638-7 · Cited by 2
HER2 (2+)/SISH-positive vs. HER2 (3+) Breast Cancer: Pre-treatment MRI Differences and Accuracy of pCR Prediction on Post-treatment MRI
Park, G. E., Mun, H. S., Kim, S. H., & Kang, B. J. (2025) · Academic Radiology · doi:10.1016/j.acra.2025.04.010 · Cited by 2
AI-CAD-Guided Mammographic Assessment of Tumor Size and T Stage: Concordance with MRI for Clinical Staging in Breast Cancer Patients Considered for NAC
Park, G. E., Shin, K., Mun, H. S., & Kang, B. J. (2025) · Tomography · doi:10.3390/tomography11070072 · Cited by 2
Imaging of the Breast
Steyerová, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-56673-3_12 · Cited by 2
Quantitative DCE-MRI of the Breast
Huang, W. (2022) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-12-822729-9.00007-2 · Cited by 2
Physicians’ Hierarchy of Tumor Biomarkers for Optimizing Chemotherapy in Breast Cancer Care
Thannickal, H. H., Eltoum, N., Henderson, N. L., Wallner, L. P., Wagner, L. I., Wolff, A. C., & Rocque, G. B. (2023) · The Oncologist · doi:10.1093/oncolo/oyad198 · Cited by 2
ROLL/SNOLL guiado por resonancia magnética en pacientes con cáncer de mama tratadas con quimioterapia neoadyuvante
Hernández-Cortes, G., Fuertes, S., Martínez, V., Rubio, M., Vera, U., Murillo, R., González‐Cortijo, L., del Cerro, E., Mohedano, R., & de la Cuesta, R. S. (2020) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2020.09.001 · Cited by 2
Reliability of MRI in Measuring the Response to Neoadjuvant Chemotherapy in Breast Cancer Patients and Its Therapeutic Implications
Mirza, S. M., O'Brien, J. P., & Aitken, J. (2016) · Breast Cancer Management · doi:10.2217/bmt-2016-0011 · Cited by 2
ASO Author Reflections: Role of Contrast-Enhanced Spectral Mammography in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy
Hilal, T., & Patel, B. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6899-2 · Cited by 2
Assessing breast cancer chemotherapy response in radiology and pathology reports via a large language model
Dodhia, P., Meepagala, S., Moallem, G., Rubin, D. L., Bean, G. R., & Rusu, M. (2024) · SPIE Medical Imaging: Imaging Informatics for Healthcare, Research, and Applications · doi:10.1117/12.3006495 · Cited by 1
Contrast-enhanced mammography and preoperative magnetic seed placement in breast cancer patients for the detection of residual disease following neoadjuvant systemic therapy
Martínez, A. M., Bravo, E. I., Alvà, H. P., Martínez, P. R., Tomas, M., Miguel, I. P., & Puyalto, P. (2024) · Radiología (English Edition) · doi:10.1016/j.rxeng.2024.04.001 · Cited by 1
Role of MRI in evaluation of residual tumor burden following neoadjuvant therapy in patients with breast cancer
Bansal, A., Vyas, S., Hari, S., Thulkar, S. P., Gogia, A., Deo, S. V. S., Srivastava, A. K., & Mathur, S. R. (2025) · Indian Journal of Breast Imaging · doi:10.25259/ijbi_25_2024 · Cited by 1
Accuracy of Breast Magnetic Resonance Imaging (MRI) and Breast Ultrasound Compared to Pathology in Assessing Residual Tumor in Breast Cancer Patients Receiving Neoadjuvant Systemic Treatment at Siriraj Hospital
Iamsamang, A., Thiravit, S., Suvannarerg, V., Rushatamukayanunt, P., Korpraphong, P., Chuthapisith, S., & Imruetaicharoenchoke, W. (2025) · Siriraj Medical Journal/San Sirirat · doi:10.33192/smj.v77i9.276157 · Cited by 1
Multi-Level Volumetric Transformer for Early Prediction of Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Verma, M., Collado‐Mesa, F., & Abdel-Mottaleb, M. S. (2026) · ACM Transactions on Computing for Healthcare · doi:10.1145/3793536 · Cited by 1
Prognostic value of circulating tumor DNA mutation panels to predict early recurrence and survival outcomes in early-stage breast cancer: a systematic review and meta-analysis
Ali, M., Imran, M. J., Hussain, J., Zakria, M., Abbasi, A. E., & Sultan, A. (2026) · Biomarkers · doi:10.1080/1354750x.2026.2633567 · Cited by 1
Mid-Treatment Delta MRI Radiomics Enhances Sensitivity and Risk Stratification for Pathological Complete Response in Breast Cancer: A Multicenter Study
Hong, L. I., Ruofan, H., Huang, W. Q., Huang, S., Xu, X., Shao, B., & Chen, H. (2026) · Academic Radiology · doi:10.1016/j.acra.2026.04.042 · Cited by 1
Therapy Response Imaging in Breast Cancer
Kataoka, M. (2020) · Medical radiology · doi:10.1007/978-3-030-31171-1_5 · Cited by 1
Contrast-Enhanced Mammography for Practicing Radiologists
Ngo, M., Kim, G., Phillips, J., Fishman, M. D. C., & Slanetz, P. J. (2022) · Advances in Clinical Radiology · doi:10.1016/j.yacr.2022.04.012 · Cited by 1
Outcomes of sentinel node biopsy according to MRI response in an association with the subtypes in cN1–3 breast cancer after neoadjuvant systemic therapy, multicenter cohort study
Bae, S. J., Chun, J. W., Lee, S. B., Ryu, J. M., Nam, S. J., Jeong, J., Park, H. S., & Ahn, S. G. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01807-8 · Cited by 1
Mamografía con contraste y marcaje con semilla magnética para la detección de enfermedad residual en el cáncer de mama tras tratamiento neoadyuvante
Martínez, A. M., Bravo, E. I., Alvà, H. P., Martínez, P. R., Tomas, M., Miguel, I. P., & de Pablo, P. P. (2024) · Radiología · doi:10.1016/j.rx.2024.04.003 · Cited by 1
Breast cancer response post neoadjuvant chemotherapy using MRI measurements
Sivaranjini, S., & Nirmala, K. (2017) · International Conference on Signal Processing, Communication and Networking (ICSCN) · doi:10.1109/icscn.2017.8085419 · Cited by 1
Contrast-Enhanced Mammography in Neoadjuvant Therapy Response Monitoring
Iotti, V., & Rossi, P. G. (2019) · Springer eBooks · doi:10.1007/978-3-030-11063-5_8 · Cited by 1
Diffusion-Weighted Magnetic Resonance Imaging of the Breast: an Accurate Method for Measuring Early Response to Neoadjuvant Chemotherapy?
Kanani, A. N., Sharma, N., & Buckley, D. L. (2019) · Current Breast Cancer Reports · doi:10.1007/s12609-019-0311-5 · Cited by 1
ASSESSMENT OF SURGICAL MANAGEMENT OF FEMALE BREAST CANCER PATIENTS AFTER NEOADJUVANT SYSTEMIC THERAPY FOR INVASIVE DUCTAL VERSUS INVASIVE LOBULAR CARCINOMA (T3 STAGE)
Douma, E.-S. A. M., Bendary, S. H., El-Agamawi, A. Y., Zayed, A. M., & El-Hameid, N. M. A. (2020) · Al-Azhar Medical Journal · doi:10.21608/amj.2020.120555 · Cited by 1
Contrast-Enhanced In-Phase Dixon Sequence: Impact on Biopsy Clip Detection on Breast MRI
Taylor-Cho, M. W., Robertson, S. H., Knight, J. R., Miller, M. M., & Baker, J. A. (2022) · American Journal of Roentgenology · doi:10.2214/ajr.22.28024 · Cited by 1
False-positive MRI Findings in Breast Cancer After Neoadjuvant Chemotherapy and Correlation Between Tumor Response Patterns and HER2 Status
Aslan, A. A., Erdemli, S., Erdoğdu, İ. H., Gültekin, S., Uras, C., Tokat, F., Arıcan, A., Özer, L., Behzatoğlu, K., Meydan, N., et al. (2023) · Acta Oncologica Turcica · doi:10.5505/aot.2023.60973 · Cited by 1
Predição de resposta patológica completa em pacientes com câncer de mama pós-quimioterapia neoadjuvante mostrando resposta radiológica completa na ressonância magnética: há um papel para a imagem
Jacinto, B. M. T. (2021) · doi:10.11606/t.5.2021.tde-07012022-094431 · Cited by 1
Mri-Based Radiomics in Breast Cancer
Granzier, R. W. Y. (2022) · doi:10.26481/dis.20220922rg · Cited by 2
Papel de la resonancia magnética de mama en la valoración de la respuesta a la neoadyuvancia
Mur, C. G., Ciria, S. C., & Senar, A. C. (2015) · Revista de Senología y Patología Mamaria · doi:10.1016/j.senol.2015.06.002
Comprehensive breast MRI: an update
Vinnicombe, S., & Petralia, G. (2014) · Cancer Imaging · doi:10.1186/1470-7330-14-s1-o39
Breast Imaging and Image-Guided Biopsy Techniques
Ganott, M. A., Griffith, B. M., & Rudzinski, S. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-22843-3_5
n eoadjuvant chemotherapy for Breast cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival—Results from the ACRIN 6657/CALGB
Hylton, N. M., Gatsonis, C. A., Rosen, M. A., Lehman, C. D., Newitt, D. C., Partridge, S. C., Bernreuter, W. K., Pisano, E. D., Morris, E. A., Weatherall, P. T., et al. (2016)
Clinical and Molecular Methods in Drug Development: Neoadjuvant Systemic Therapy in Breast Cancer as a Model
Braga, S. A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3347-1_15
Forme avancée de carcinome infiltrant
Mery, E., Charitansky, H., Dalenc, F., Boulet, B., & Massabeau, C. (2016) · Elsevier eBooks · doi:10.1016/b978-2-294-74449-5.00019-8
Magnetic Resonance Imaging and Neoadjuvant Chemotherapy
Le‐Petross, H. T., Lim, B., & Hylton, N. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-42563-4_5
Personalized Medicine, Biomarkers of Risk and Breast MRI
Sutton, E. J., Purvis, N., Pinker, K., & Morris, E. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-42563-4_17
IRM du sein dans le carcinome lobulaire infiltrant : aspects diagnostiques, bilan préthérapeutique, évaluation sous hormono- ou chimio-néo-adjuvante
Dratwa, C., Sebbag-Sfez, D., & Thibault, F. E. (2017) · Imagerie de la Femme · doi:10.1016/j.femme.2017.09.001
Neoadjuvant chemotherapy in breast cancer
Vriens (2017) · doi:10.26481/dis.20171213bv
Comment optimiser le bilan préopératoire d’un cancer du sein éligible à un traitement oncoplastique ?
Molière, S., Roedlich, M. N., Bodin, F., Robert, É., & Mathelin, C. (2019) · Imagerie de la Femme · doi:10.1016/j.femme.2019.01.002
Correlation of Pathologic and Radiologic Complete Response in the Axilla after Neoadjuvant Chemotherapy for Breast Cancer
Gooch, J. C., Timothy, B., Chun, J., Elianna, K., Guth, A. A., Deborah, A., Richard, S., Linda, M. S., & Freya, S. (2019) · International Journal of Radiology and Imaging Technology · doi:10.23937/2572-3235.1510056
Correlación del grado de respuesta tras quimioterapia neoadyuvante, en pacientes con Ca de mama con fenotipo triple negativo. RM vs anatomía patológica.
Fernandez, J. J. M., García, M. L., Rodrigo, S. P., Agustín, M. C. D., & Muñoz, L. F. (2018) · Seram
Neoadjuvant Chemotherapy and Biomarkers
Chotai, N. C., & Kulkarni, S. R. (2020) · Springer eBooks · doi:10.1007/978-981-15-1412-8_15
Podudarnost procijenjene veličine rezidualnog tumorskog procesa magnetskom rezonancijom i patohistološkom dijagnostikom u pacijentica s karcinomom dojke nakon provedene neoadjuvantne kemoterapije
Černeka, E., Miletić, D., Avirović, M., Grebić, D., & Zujić, P. V. (2020) · Medicina Fluminensis · doi:10.21860/medflum2020_237302
Response Assessment and Follow-Up by Imaging in Breast Tumors
Goethem, M. V., Castello, A., Lobbes, M. B. I., Rose, F. D., Scorsetti, M., & Lopci, E. (2020) · Medical radiology · doi:10.1007/978-3-030-38261-2_24
Self-citation
Role of breast imaging with histopathological correlation in evaluating the response of locally advanced breast cancer to neoadjuvant chemotherapy
Syed, A., Premi, V., Varghese, R. P., Arora, M., Kapoor, A., Satish Chaitanya, K., Sharda, P., Gupta, M., & Ravi, B. (2020) · The Breast Journal · doi:10.1111/tbj.13996
Magnetic resonance-guided ROLL/SNOLL in breast cancer patients treated with neoadjuvant chemotherapy
Hernández-Cortes, G., Fuertes, S., Martinez, V., Rubio, M., Vera, U., Murillo, R., González‐Cortijo, L., del Cerro, E., Mohedano, R., & de la Cuesta, R. S. (2020) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2020.12.003
Prospective Explore of Clinical-Pathological Shrinkage Modes After Neoadjuvant Therapy in Breast CancerPreprint
Bi, Z., Zhang, Z.-P., Xu, C.-J., Chen, P., Qiu, P., Zhao, T., & Wang, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-960396/v1

Authors: Lobbes, M. B. I., Prevos, R., Smidt, M., Tjan-Heijnen, V. C. G., van Goethem, M., Schipper, R., Beets-Tan, R. G., & Wildberger, J. E.
Affiliations: Maastricht University Medical Centre (NL)
Corresponding author: Lobbes, M. B. I.
ORCID: Lobbes, M. B. I.
Smidt, M.
Schipper, R.
Wildberger, J. E.
Venue: Insights into Imaging
Publisher: Springer Science and Business Media LLC
Published: 2013-01-29
Volume: 4
Issue: 2
Pages: 163-175
ISSN: 1869-4101 (ISSN-L)
DOI: 10.1007/s13244-013-0219-y
PMC: PMC3609956
OpenAlex: W2057016707
Cited by: 237
References: 56
Citations by year: 2026: 10 · 2025: 15 · 2024: 27 · 2023: 21 · 2022: 22 · 2021: 25 · 2020: 15 · 2019: 23 · 2018: 16 · 2017: 24 · 2016: 16 · 2015: 11 · 2014: 8 · 2013: 4
FWCI: 1.84
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by-nc/2.0 (unspecified)
Locations: Insights into Imaging (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Research Publications (Maastricht University) (publishedVersion, cc-by)
Research Publications (Maastricht University) (submittedVersion, cc-by)
Topics: Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords: breast MRI, residual disease, pathological complete response, neoadjuvant chemotherapy, invasive breast cancer, diagnostic accuracy, breast cancer subtypes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks